Insider Trading History of Langer Dennis

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Langer Dennis since 2007. This trader's CIK number is 1274225. At the time of last reporting, Langer Dennis was the Officer of Quoin Pharmaceuticals, Ltd.. (stock ticker symbol QNRX). Also see all insider trading activities at Quoin Pharmaceuticals, Ltd..

Note that in the past LANGER DENNIS also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Dicerna Pharmaceuticals Inc (DRNA) by Langer Dennis

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 DRNA 0 $0 38,341 $613,456 360 $1,231
2016 DRNA 0 $0 23,766 $83,656 34,722 $118,749

Yearly summary of insider trading at Myriad Genetics Inc (MYGN) by Langer Dennis

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 MYGN 0 $0 30,000 $1,042,500 30,000 $761,700
2018 MYGN 0 $0 90,000 $3,490,120 90,000 $2,099,923
2012 MYGN 0 $0 70,000 $2,091,225 70,000 $1,195,950
2009 MYGN 0 $0 15,000 $1,240,725 15,000 $386,025
2008 MYGN 0 $0 10,000 $647,749 10,000 $214,899
2007 MYGN 0 $0 30,000 $1,427,530 30,000 $554,040

Yearly summary of insider trading at Quoin Pharmaceuticals, Ltd. (QNRX) by Langer Dennis

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 QNRX 0 $0 297 $217 0 $0


Insider trading activities at 3 companies by Langer Dennis:

1. Dicerna Pharmaceuticals Inc (DRNA)

2. Myriad Genetics Inc (MYGN)

3. Quoin Pharmaceuticals, Ltd. (QNRX)

Table 1. Insider trading of Dicerna Pharmaceuticals Inc (DRNA) by Langer Dennis

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-08-15 DRNA Sale 38,341 16.00 613,456
2018-01-26 DRNA Option Ex 360 3.42 1,231
2016-11-16 DRNA Sale 23,766 3.52 83,656
2016-02-03 DRNA Option Ex 34,722 3.42 118,749

Table 2. Insider trading of Myriad Genetics Inc (MYGN) by Langer Dennis

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-08-03 MYGN Option Ex 30,000 25.39 761,700
2021-08-03 MYGN Sale 30,000 34.75 1,042,500
2018-06-08 MYGN Sale 13,664 39.35 537,678
2018-06-07 MYGN Sale 3,096 39.35 121,827
2018-06-08 MYGN Option Ex 13,664 21.29 290,906
2018-06-06 MYGN Sale 3,609 39.37 142,089
2018-06-07 MYGN Option Ex 3,096 21.29 65,913
2018-06-06 MYGN Option Ex 3,609 21.29 76,835
2018-06-01 MYGN Option Ex 30,000 24.40 732,000
2018-06-05 MYGN Sale 1,227 39.90 48,957
2018-06-04 MYGN Sale 18,404 39.90 734,319
2018-06-05 MYGN Option Ex 1,227 21.29 26,122
2018-06-04 MYGN Option Ex 18,404 22.84 420,347
2018-06-01 MYGN Sale 30,000 38.90 1,167,000
2018-05-30 MYGN Option Ex 10,000 24.39 243,900
2018-05-30 MYGN Sale 10,000 37.92 379,250
2018-05-21 MYGN Option Ex 10,000 24.39 243,900
2018-05-21 MYGN Sale 10,000 35.90 359,000
2012-11-29 MYGN Option Ex 25,000 13.53 338,250
2012-11-30 MYGN Option Ex 45,000 19.06 857,700
2012-11-29 MYGN Sale 25,000 29.82 745,500
2012-11-30 MYGN Sale 45,000 29.91 1,345,725
2009-02-05 MYGN Sale 15,000 82.72 1,240,725
2009-02-05 MYGN Option Ex 15,000 25.73 386,025
2008-09-04 MYGN Option Ex 5,720 21.49 122,922
2008-09-05 MYGN Option Ex 4,280 21.49 91,977
2008-09-04 MYGN Sale 5,720 65.73 375,969
2008-09-05 MYGN Sale 4,280 63.50 271,780
2007-12-19 MYGN Option Ex 10,000 17.23 172,300
2007-12-20 MYGN Option Ex 20,000 19.09 381,740
2007-12-19 MYGN Sale 10,000 47.52 475,150
2007-12-20 MYGN Sale 20,000 47.62 952,380

Table 3. Insider trading of Quoin Pharmaceuticals, Ltd. (QNRX) by Langer Dennis

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-06-07 QNRX Sale 297 .73 217

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Langer Dennis (Officer of Quoin Pharmaceuticals, Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.